Skip to main content
. 2023 Dec 4;15(Suppl 2):ii3–ii11. doi: 10.1093/inthealth/ihad069

Table 2.

Age-adjusted prevalence of antibodies to Pgp3 and Ct694 antigens, Bondoukou 1 and Bangolo 2, Côte d'Ivoire, 2021

Age-adjusted prevalence of Pgp3, % (95% CI) Age-adjusted prevalence of Ct694, % (95% CI)
EU 1–9 y ≥15 y 1–9 y ≥15 y
Boudoukou 1 5.3
(1.5 to 15.6)
57.0
(39.1 to 74.0)
5.2
(1.2 to 15.6)
33.8
(19.4 to 53.4)
Bangolo 2 8.2
(4.7 to 13.7)
73.6
(61.0 to 83.8)
8.7
(5.1 to 14.3)
56.8
(44.4 to 69.0)